SCHEMBL13367494

SCHEMBL13367494

CN(c1ccc(-c2ccccc2)cc1)c1nccc2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.48
EGFR P00533 1/20 0.46
S100A4 P26447 1/20 0.43
CYP2A6 P11509 1/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
CNR2 P34972 1/20 0.43
KCNH2 Q12809 1/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 2/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367359 0.90 EGFR (0.56) PDE5AEGFRS100A4CYP2A6CNR2
SCHEMBL31098990 0.86 CYP2A6 (0.49) EGFRS100A4CYP2A6CNR2KDM4E
SCHEMBL13367560 0.86 CYP2A6 (0.49) EGFRS100A4CYP2A6CNR2KDM4E
SCHEMBL31098986 0.84 S100A4 (0.43) PDE5AEGFRS100A4CYP2A6ABCG2
SCHEMBL13367553 0.83 CYP2A6 (0.55) EGFRS100A4CYP2A6CNR2KDM4E
SCHEMBL3113118 0.82 EGFR (0.57) EGFR
SCHEMBL13367444 0.81 S100A4 (0.43) PDE5AEGFRS100A4CYP2A6CNR2
SCHEMBL13338707 0.81 LMNA (0.40) S100A4CYP2A6CNR2KCNH2KDM4E
SCHEMBL13367577 0.78 CYP2A6 (0.47) EGFRS100A4CYP2A6CNR2KMT2A
SCHEMBL13231255 0.78 KCNH2 (0.39) PDE5AS100A4CYP2A6CNR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 PDE5A 4323/4885EGFR 1659/4885S100A4 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.